RESEARCH & CLINICAL TRIALS
RESP® Biosensor
Continuous, clinically validated cough monitoring and lung sound capture for drug development and research studies
FDA 510(k) Class II Device | CE Mark | HIPAA Compliant
Cough and wheeze are highly prevalent, burdensome symptoms across many respiratory and infectious diseases. Patient-reported outcomes (PROs), while valuable, may not fully capture the reality these symptoms present. The RESP® Biosensor measures the full scope of respiratory symptoms and other insights, providing additional objective data and insights alongside PROs and pulmonary function tests.
Technology Overview
Unlock 24-hour clinically accurate and continuous monitoring of cough and lung sounds with the RESP® Biosensor. Optimized for ease of use at home as part of clinical trials, our cough monitoring device offers:
- Enhanced Patient Compliance: A wireless, discreet design that respects patient comfort and lifestyle.
- Rapid, Reliable Data Access: Direct cloud sync facilitates efficient analysis of objective respiratory metrics.
- Superior and Comprehensive Data: Captures detailed cough and lung sound data, offering objective insight alongside PROs.
RESP® Biosensor Measures
Cough Monitoring
24-Hour Cough Frequency, Intensity* and Bouts
Lung Sounds
Additional Insights*
*For investigational use only
Why Choose the RESP® Biosensor for Cough Monitoring?
Privacy & Security
Accelerated Insights
Subject Cough Only
Multi-modal data are used to differentiate between subject coughs and external coughs.
Patient Friendly
Comprehensive Data
Extended measurements beyond cough frequency allow for a greater understanding of lung health and subject quality of life.
Metrics-at-a-Glance
600k+
19m+
4
35
2
1
Clinical Trial Therapeutic Areas
Using a combination of audio and motion data, the RESP Biosensor unlocks valuable insight across multiple indications, offering a more complete picture of subjects’ respiratory status and health-related quality of life alongside PROs.
Cough | Wheeze | Crackles | Respiratory Rate* | Activity Levels* | Sleep/Wake* | Body Positioning* | |
Chronic Cough | |||||||
IPF | |||||||
Bronchitis | |||||||
COPD | |||||||
Asthma | |||||||
RSV | |||||||
Covid-19 | |||||||
Heart Failure |
- Chronic Cough
- IPF
- Bronchitis
- COPD
- Asthma
- RSV
- Covid-19
- Heart Failure
*For investigational use only
A Cough Monitoring Device Designed for Daily Life
- Compared to bulkier alternatives, the RESP Biosensor
reduces subject and site burden. - Wireless and discreet, subjects report that they forget the cough monitoring device is on.
- Sleek design helps ensure patients behave naturally,
capturing authentic symptom data that mirrors real-life
conditions.
Validated Overread and Event Annotation Process
- Our cough counting approach includes a consensus labeling process to ensure the highest level of accuracy and to meet endpoint requirements.
- Machine learning algorithms* for automated cough counting have also been performance-tested to meet customer requirements.
- Algorithms* allow for compression of cough recordings for human annotation or can be used independently for subject screening and other applications.
**Machine learning algorithms not FDA-cleared
Visual spectrograms of lung sound events facilitate overread for trained specialists
Cough
Wheeze
Crackles
Clinical Validation
Request a Demo
Explore using the RESP® Biosensor in your next study